Nothing Special   »   [go: up one dir, main page]
create a website
Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals.. (1988). Hurwitz, Mark A ; Caves, Richard E.
In: Journal of Law and Economics.
RePEc:ucp:jlawec:v:31:y:1988:i:2:p:299-320.

Full description at Econpapers || Download paper

Cited: 96

Citations received by this document

Cites: 0

References cited by this document

Cocites: 0

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. Multi-battle contests over complementary battlefields. (2023). Stephenson, Daniel Graydon.
    In: Working Papers.
    RePEc:vcu:wpaper:2303.

    Full description at Econpapers || Download paper

  2. Off the mark? What we (should) know about the bright and dark sides of corporate trademark practices. (2023). Castaldi, Carolina.
    In: Industrial and Corporate Change.
    RePEc:oup:indcch:v:32:y:2023:i:5:p:1046-1062..

    Full description at Econpapers || Download paper

  3. Advertising persuasion in dual markets. (2021). Keswani, Aneel ; Vakratsas, Demetrios ; Stolin, David.
    In: Managerial and Decision Economics.
    RePEc:wly:mgtdec:v:42:y:2021:i:1:p:239-245.

    Full description at Econpapers || Download paper

  4. Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions. (2021). Bennato, Anna Rita ; Mariuzzo, Franco.
    In: Small Business Economics.
    RePEc:kap:sbusec:v:57:y:2021:i:1:d:10.1007_s11187-019-00307-w.

    Full description at Econpapers || Download paper

  5. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

  6. The Unexpected Consequences of Generic Entry. (2019). Ornaghi, Carmine ; Castanheira, Micael ; Siotis, Georges ; de Moura, Micael Castanheira .
    In: ULB Institutional Repository.
    RePEc:ulb:ulbeco:2013/298643.

    Full description at Econpapers || Download paper

  7. Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions. (2019). , Farasat ; Bennato, Anna Rita ; Mariuzzo, Franco.
    In: Working Paper series, University of East Anglia, Centre for Competition Policy (CCP).
    RePEc:uea:ueaccp:2016_01v3.

    Full description at Econpapers || Download paper

  8. An enforced loop-out knowledge flow facilitates industry competition: Learning from the pharmaceutical and genetically modified seed industries. (2019). Chang, Ching-Wen ; Kano, Shingo ; Yamanaka, Takayuki.
    In: Technovation.
    RePEc:eee:techno:v:79:y:2019:i:c:p:11-24.

    Full description at Econpapers || Download paper

  9. The unexpected consequences of generic entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:68:y:2019:i:c:s0167629618305332.

    Full description at Econpapers || Download paper

  10. The Unexpected Consequences of Generic Entry. (2019). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael.
    In: Working Papers ECARES.
    RePEc:eca:wpaper:2013/293928.

    Full description at Econpapers || Download paper

  11. Common ownership and market entry: Evidence from the pharmaceutical industry. (2018). Seldeslachts, Jo ; Banal-Estanol, Albert ; Banal-Estaol, Albert ; Newham, Melisa.
    In: Economics Working Papers.
    RePEc:upf:upfgen:1612.

    Full description at Econpapers || Download paper

  12. Brand Loyalty and Generic Entry: Why Do Brand-Name Drug Companies Launch Their Own Generics?. (2018). Wan, Yunyun.
    In: The Japanese Economic Review.
    RePEc:spr:jecrev:v:69:y:2018:i:3:d:10.1111_jere.12189.

    Full description at Econpapers || Download paper

  13. Common Ownership and Market Entry: Evidence from Pharmaceutical Industry. (2018). Seldeslachts, Jo ; Banal-Estanol, Albert ; Newham, Melissa.
    In: Discussion Papers of DIW Berlin.
    RePEc:diw:diwwpp:dp1738.

    Full description at Econpapers || Download paper

  14. Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry. (2018). Seldeslachts, Jo ; Banal-Estanol, Albert ; Newham, M.
    In: Working Papers.
    RePEc:cty:dpaper:18/03.

    Full description at Econpapers || Download paper

  15. Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry. (2018). Seldeslachts, Jo ; Banal-Estanol, Albert ; Newham, Melissa ; Banal-Estaol, Albert.
    In: Working Papers.
    RePEc:bge:wpaper:1042.

    Full description at Econpapers || Download paper

  16. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:be3f3c38-5e39-4a67-af57-820c14957e0b.

    Full description at Econpapers || Download paper

  17. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Other publications TiSEM.
    RePEc:tiu:tiutis:6ee607fc-8602-4270-a076-3b0a18f71366.

    Full description at Econpapers || Download paper

  18. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiutil:be3f3c38-5e39-4a67-af57-820c14957e0b.

    Full description at Econpapers || Download paper

  19. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiucen:6ee607fc-8602-4270-a076-3b0a18f71366.

    Full description at Econpapers || Download paper

  20. The Unexpected Consequences of Asymmetric Competition. An Application to Big Pharma. (2017). Siotis, Georges ; Ornaghi, Carmine ; Castanheira, Micael ; de Frutos, Maria-Angeles .
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:11813.

    Full description at Econpapers || Download paper

  21. The Formation of Consumer Brand Preferences. (2016). Bronnenberg, Bart J ; Dube, Jean-Pierre H.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:22691.

    Full description at Econpapers || Download paper

  22. The Formation of Consumer Brand Preferences. (2016). Bronnenberg, Bart ; Dube, Jean-Pierre.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:11648.

    Full description at Econpapers || Download paper

  23. Skimming or Penetration? Strategic Dynamic Pricing for New Products. (2015). Spann, Martin ; Fischer, Marc ; Tellis, Gerard J.
    In: Marketing Science.
    RePEc:inm:ormksc:v:34:y:2015:i:2:p:235-249.

    Full description at Econpapers || Download paper

  24. Regulation of the Pharmaceutical-Biotechnology Industry. (2014). Keuffel, Eric ; Danzon, Patricia M..
    In: NBER Chapters.
    RePEc:nbr:nberch:12572.

    Full description at Econpapers || Download paper

  25. Competitive diffusion of new prescription drugs: The role of pharmaceutical marketing investment. (2014). Ruiz-Conde, Enar ; PEter, ; Wieringa, Jaap E.
    In: Technological Forecasting and Social Change.
    RePEc:eee:tefoso:v:88:y:2014:i:c:p:49-63.

    Full description at Econpapers || Download paper

  26. Price regulation and relative delays in generic drug adoption. (2014). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Costa-Font, Joan ; costa -Font, Joan .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:38:y:2014:i:c:p:1-9.

    Full description at Econpapers || Download paper

  27. Information technology and agency in physicians prescribing decisions. (2014). Epstein, Andrew J. ; Ketcham, Jonathan D..
    In: RAND Journal of Economics.
    RePEc:bla:randje:v:45:y:2014:i:2:p:422-448.

    Full description at Econpapers || Download paper

  28. Competition in prescription drug markets: the roles of trademarks, advertising, and generic names. (2013). Lobo, Félix ; Feldman, Roger.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:14:y:2013:i:4:p:667-675.

    Full description at Econpapers || Download paper

  29. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity. (2013). Cockburn, Iain ; Bosworth, Barry ; Frank, Richard ; Aitken, Murray L. ; Kleinrock, Michael ; Berndt, Ernst R. ; Shapiro, Bradley T..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19487.

    Full description at Econpapers || Download paper

  30. Effects of Pharmaceutical Promotion: A Review and Assessment. (2013). Dave, Dhaval.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:18830.

    Full description at Econpapers || Download paper

  31. The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales following Loss of Exclusivity. (2013). Bosworth, Barry ; Frank, Richard ; Aitken, Murray L. ; Kleinrock, Michael ; Cockburn, Iain ; Berndt, Ernst R. ; Shapiro, Bradley.
    In: NBER Chapters.
    RePEc:nbr:nberch:13094.

    Full description at Econpapers || Download paper

  32. Treatment Effectiveness and Side Effects: A Model of Physician Learning. (2013). Chan, Tat ; Narasimhan, Chakravarthi ; Xie, Ying.
    In: Management Science.
    RePEc:inm:ormnsc:v:59:y:2013:i:6:p:1309-1325.

    Full description at Econpapers || Download paper

  33. Pricing dynamics and product quality: the case of antidepressant drugs. (2012). Rizzo, John ; Chen, Jie.
    In: Empirical Economics.
    RePEc:spr:empeco:v:42:y:2012:i:1:p:279-300.

    Full description at Econpapers || Download paper

  34. Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions. (2012). Ching, Andrew ; Ishihara, Masakazu.
    In: Management Science.
    RePEc:inm:ormnsc:v:58:y:2012:i:7:p:1374-1387.

    Full description at Econpapers || Download paper

  35. Direct to Consumer Advertising for Pharmaceuticals: Research Amid the Controversy. (2012). Kleit, Andrew N. ; Bradford, David W..
    In: Chapters.
    RePEc:elg:eechap:14021_31.

    Full description at Econpapers || Download paper

  36. Pricing of drugs with heterogeneous health insurance coverage. (2012). Missios, Paul ; Ferrara, Ida.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:31:y:2012:i:2:p:440-456.

    Full description at Econpapers || Download paper

  37. Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry. (2011). Higgins, Matthew ; Chatterjee, Chirantan ; Branstetter, Lee G..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17188.

    Full description at Econpapers || Download paper

  38. Side Effects of Competition: the Role of Advertising and Promotion in Pharmaceutical Markets. (2011). Markowitz, Sara ; David, Guy.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17162.

    Full description at Econpapers || Download paper

  39. Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008. (2011). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Joan Costa-i-Font, ; Joan Costa-i-Font, .
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_3441.

    Full description at Econpapers || Download paper

  40. Does Patient Use of Medical Information Affect Physician Practice Incentives to Provide Care?. (2011). Rizzo, John ; Fang, Hai .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:14:y:2011:i:2:n:2.

    Full description at Econpapers || Download paper

  41. Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration. (2011). Ellison, Glenn.
    In: American Economic Journal: Microeconomics.
    RePEc:aea:aejmic:v:3:y:2011:i:1:p:1-36.

    Full description at Econpapers || Download paper

  42. Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry. (2010). Appelt, Silvia .
    In: Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems.
    RePEc:trf:wpaper:357.

    Full description at Econpapers || Download paper

  43. Pricing of Drugs with Heterogeneous Health Insurance Coverage. (2010). Missios, Paul ; Ferrara, Ida.
    In: Working Papers.
    RePEc:rye:wpaper:wp026.

    Full description at Econpapers || Download paper

  44. Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry. (2010). Appelt, Silvia .
    In: Discussion Papers in Economics.
    RePEc:lmu:muenec:11476.

    Full description at Econpapers || Download paper

  45. Modeling the effects of pharmaceutical marketing. (2010). Leeflang, Peter ; Wieringa, Jaap.
    In: Marketing Letters.
    RePEc:kap:mktlet:v:21:y:2010:i:2:p:121-133.

    Full description at Econpapers || Download paper

  46. Retail price regulation and innovation: Reference pricing in the pharmaceutical industry. (2010). Jullien, Bruno ; Bommier, Antoine ; Bardey, David.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:29:y:2010:i:2:p:303-316.

    Full description at Econpapers || Download paper

  47. THE EFFECT OF DIRECT TO CONSUMER TELEVISION ADVERTISING ON THE TIMING OF TREATMENT. (2010). Bradford, W. David ; Kleit, Andrew N. ; Ornstein, Steven ; Nietert, Paul J..
    In: Economic Inquiry.
    RePEc:bla:ecinqu:v:48:y:2010:i:2:p:306-322.

    Full description at Econpapers || Download paper

  48. Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry. (2009). Jullien, Bruno ; Bommier, Antoine ; Bardey, David.
    In: TSE Working Papers.
    RePEc:tse:wpaper:21920.

    Full description at Econpapers || Download paper

  49. The influence of managed care on generic prescribing rates: an analysis of HMO physicians. (2009). Rice, Jennifer .
    In: Applied Economics.
    RePEc:taf:applec:v:43:y:2009:i:7:p:787-796.

    Full description at Econpapers || Download paper

  50. Direct-to-Consumer Advertising of Prescription Drugs: A Strategic Analysis. (2009). HE, CHUAN ; Amaldoss, Wilfred .
    In: Marketing Science.
    RePEc:inm:ormksc:v:28:y:2009:i:3:p:472-487.

    Full description at Econpapers || Download paper

  51. Heterogeneous Learning and the Targeting of Marketing Communication for New Products. (2009). Manchanda, Puneet ; Narayanan, Sridhar.
    In: Marketing Science.
    RePEc:inm:ormksc:v:28:y:2009:i:3:p:424-441.

    Full description at Econpapers || Download paper

  52. Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry. (2009). Jullien, Bruno ; Bommier, Antoine ; Bardey, David.
    In: IDEI Working Papers.
    RePEc:ide:wpaper:6733.

    Full description at Econpapers || Download paper

  53. CUT-THROAT FRINGE COMPETITION IN AN EMERGING COUNTRY MARKET: TAX EVASION OR THE ABSENCE OF MARKET POWER? -super-*. (2009). Salvo, Alberto.
    In: Journal of Industrial Economics.
    RePEc:bla:jindec:v:57:y:2009:i:4:p:677-711.

    Full description at Econpapers || Download paper

  54. Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst ; Koss, Catherine ; Frank, Richard.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

    Full description at Econpapers || Download paper

  55. Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules. (2008). Gonzalez, Jorge ; Stern, Philip ; Dutta, Shantanu ; Sismeiro, Catarina.
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:25:y:2008:i:4:p:247-260.

    Full description at Econpapers || Download paper

  56. Generalizations on the effectiveness of pharmaceutical promotional expenditures. (2008). , Sara ; Wieringa, Jaap E ; PEter, .
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:25:y:2008:i:4:p:234-246.

    Full description at Econpapers || Download paper

  57. Pharmaceutical Patents: Incentives for R&D or Marketing?. (2008). Straume, Odd Rune ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_2433.

    Full description at Econpapers || Download paper

  58. Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs. (2008). Linnosmaa, Ismo.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:8:y:2008:i:2:n:8.

    Full description at Econpapers || Download paper

  59. Entry into Banking Markets and the Early‐Mover Advantage. (2007). Dick, Astrid A ; Berger, Allen N.
    In: Journal of Money, Credit and Banking.
    RePEc:wly:jmoncb:v:39:y:2007:i:4:p:775-807.

    Full description at Econpapers || Download paper

  60. The Effects of Detailing on Prescribing Decisions under Two-Sided Learning. (2007). Ching, Andrew ; Ishihara, Masakazu.
    In: MPRA Paper.
    RePEc:pra:mprapa:4935.

    Full description at Econpapers || Download paper

  61. Market Effects of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors. (2007). Sismeiro, Catarina ; Dutta, Shantanu ; Stern, Philip ; Gonzalez, Jorge.
    In: MPRA Paper.
    RePEc:pra:mprapa:3717.

    Full description at Econpapers || Download paper

  62. Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration. (2007). Ellison, Glenn.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:13069.

    Full description at Econpapers || Download paper

  63. The Effect of Advertising on Pharmaceutical Innovation. (2007). Norton, Edward ; Kwong, Winghan.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:31:y:2007:i:3:p:221-236.

    Full description at Econpapers || Download paper

  64. Economic Policy in Health Care: Sickness Absence and Pharmaceutical Cost. (2007). Granlund, David.
    In: Umeå Economic Studies.
    RePEc:hhs:umnees:0710.

    Full description at Econpapers || Download paper

  65. Consumer Information and Pharmaceutical Prices: Theory and Evidence. (2007). Granlund, David ; Rudholm, Niklas.
    In: Umeå Economic Studies.
    RePEc:hhs:umnees:0709.

    Full description at Econpapers || Download paper

  66. Consumer Information and Pharmaceutical Prices: Theory and Evidence. (2007). Granlund, David ; Rudholm, Niklas.
    In: HUI Working Papers.
    RePEc:hhs:huiwps:0008.

    Full description at Econpapers || Download paper

  67. Advertising and generic market entry. (2007). Konigbauer, Ingrid .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:26:y:2007:i:2:p:286-305.

    Full description at Econpapers || Download paper

  68. Pharmaceutical promotion and GP prescription behaviour. (2006). Windmeijer, Frank ; de Laat, Eric ; Douven, Rudy ; Mot, Esther .
    In: Health Economics.
    RePEc:wly:hlthec:v:15:y:2006:i:1:p:5-18.

    Full description at Econpapers || Download paper

  69. Dealing with Rising Health Care Costs: The Case of Pharmaceuticals. (2006). Konigbauer, Ingrid .
    In: Munich Dissertations in Economics.
    RePEc:lmu:dissen:5640.

    Full description at Econpapers || Download paper

  70. Market Power, Brand Characteristics and Demand for Retail Grocery Products. (2006). Webster, Elizabeth ; Jensen, Paul.
    In: Melbourne Institute Working Paper Series.
    RePEc:iae:iaewps:wp2006n05.

    Full description at Econpapers || Download paper

  71. Direct to consumer advertising in pharmaceutical markets. (2006). Kuhn, Michael ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:25:y:2006:i:1:p:102-130.

    Full description at Econpapers || Download paper

  72. The Competitive Effects of Drug Withdrawals. (2005). Rizzo, John ; Cawley, John.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11223.

    Full description at Econpapers || Download paper

  73. Strategic Pricing and Detailing Behavior in International Markets. (2005). Desiraju, Ramarao ; Chintagunta, Pradeep.
    In: Marketing Science.
    RePEc:inm:ormksc:v:24:y:2005:i:1:p:67-80.

    Full description at Econpapers || Download paper

  74. Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN. (2005). SALERNO, Nicola ; Pammolli, Fabio ; Magazzini, Laura ; Papa, Gianluca .
    In: Working Papers CERM.
    RePEc:ern:wpaper:01-2005.

    Full description at Econpapers || Download paper

  75. Direct to Consumer Advertising in Pharmaceutical Markets. (2005). Kuhn, Michael ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_1493.

    Full description at Econpapers || Download paper

  76. Competition and Advertising in Specialized Markets: A Study of the U.S. Pharmaceutical Industry. (2005). Bhattacharyya, Amrita.
    In: Boston College Working Papers in Economics.
    RePEc:boc:bocoec:624.

    Full description at Econpapers || Download paper

  77. Advertising in Specialized Markets: Example from the US Pharmaceutical Industry. (2005). Bhattacharyya, Amrita.
    In: Boston College Working Papers in Economics.
    RePEc:boc:bocoec:610.

    Full description at Econpapers || Download paper

  78. The Effect of Prescription Drug Advertising on Doctor Visits. (2005). Iizuka, Toshiaki ; Jin, Ginger Zhe.
    In: Journal of Economics & Management Strategy.
    RePEc:bla:jemstr:v:14:y:2005:i:3:p:701-727.

    Full description at Econpapers || Download paper

  79. Dynamic competition in pharmaceuticals. (2004). Riccaboni, Massimo ; Pammolli, Fabio ; Magazzini, Laura.
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:5:y:2004:i:2:p:175-182.

    Full description at Econpapers || Download paper

  80. Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure. (2004). Riccaboni, Massimo ; Pammolli, Fabio ; Magazzini, Laura.
    In: MPRA Paper.
    RePEc:pra:mprapa:15968.

    Full description at Econpapers || Download paper

  81. Pharmaceutical promotion and GP prescription behaviour. (2004). Windmeijer, Frank ; de Laat, Eric ; Douven, Rudy ; Mot, Esther .
    In: CPB Discussion Paper.
    RePEc:cpb:discus:30.

    Full description at Econpapers || Download paper

  82. What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs?. (2004). Iizuka, Toshiaki.
    In: Journal of Industrial Economics.
    RePEc:bla:jindec:v:52:y:2004:i:3:p:349-379.

    Full description at Econpapers || Download paper

  83. Competition and substitutability in the Swedish pharmaceuticals market. (2003). Rudholm, Niklas.
    In: Applied Economics.
    RePEc:taf:applec:v:35:y:2003:i:14:p:1609-1617.

    Full description at Econpapers || Download paper

  84. Prescription Drug Advertising and Patient Compliance: A Physician Agency Approach. (2003). Armantier, Olivier ; Namaro, Soiliou Daw.
    In: Department of Economics Working Papers.
    RePEc:nys:sunysb:03-01.

    Full description at Econpapers || Download paper

  85. Demand Effects of Recent Changes in Prescription Drug Promotion. (2003). Epstein, Arnold M. ; Frank, Richard G. ; Rosenthal, Meredith B. ; Donohue, Julie M. ; Berndt, Ernst R..
    In: NBER Chapters.
    RePEc:nbr:nberch:9862.

    Full description at Econpapers || Download paper

  86. Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales. (2002). Kyle, Margaret ; Ling, Davina C. ; Berndt, Ernst R..
    In: Journal of Law and Economics.
    RePEc:ucp:jlawec:doi:10.1086/368004.

    Full description at Econpapers || Download paper

  87. First-mover advantages in regimes of weak appropriability: the case of financial services innovations. (2002). Roberts, Edward B. ; Lopez, Luis E..
    In: Journal of Business Research.
    RePEc:eee:jbrese:v:55:y:2002:i:12:p:997-1005.

    Full description at Econpapers || Download paper

  88. Impact of Patents on Access to HIV/AIDS Drugs in Developing Countries. (2002). Borrell, Joan-Ramon ; Watal, Jayashree.
    In: CID Working Papers.
    RePEc:cid:wpfacu:92.

    Full description at Econpapers || Download paper

  89. Do Pharmaceutical Sales Respond to Scientific Evidence?. (2002). Azoulay, Pierre.
    In: Journal of Economics & Management Strategy.
    RePEc:bla:jemstr:v:11:y:2002:i:4:p:551-594.

    Full description at Econpapers || Download paper

  90. The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro Data. (2001). Aronsson, Thomas ; Rudholm, Niklas ; Bergman, Mats .
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:19:y:2001:i:4:p:423-433.

    Full description at Econpapers || Download paper

  91. Moral hazard in physician prescription behavior. (2000). Lundin, Douglas .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:19:y:2000:i:5:p:639-662.

    Full description at Econpapers || Download paper

  92. Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. (2000). Scott Morton, Fiona M., .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:18:y:2000:i:7:p:1085-1104.

    Full description at Econpapers || Download paper

  93. Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs.. (1999). Rizzo, John.
    In: Journal of Law and Economics.
    RePEc:ucp:jlawec:v:42:y:1999:i:1:p:89-116.

    Full description at Econpapers || Download paper

  94. First-mover advantages and path dependence. (1997). Mueller, Dennis.
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:15:y:1997:i:6:p:827-850.

    Full description at Econpapers || Download paper

  95. Price regulation in the pharmaceutical industry: Prescription or placebo?. (1995). Abbott, Thomas III.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:14:y:1995:i:5:p:551-565.

    Full description at Econpapers || Download paper

  96. Abstract. (1993). Dierickx, Ingemar ; Cool, Karel.
    In: Strategic Management Journal.
    RePEc:bla:stratm:v:14:y:1993:i:1:p:47-59.

    Full description at Econpapers || Download paper

References

References cited by this document

    This document has not been processed yet.

    You may help us by submiting the list of references

Cocites

Documents in RePEc which have cited the same bibliography

          This document has not co-citation data yet.

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-02-01 10:17:01 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.